The impact of preanalytical variables on measuring cerebrospinal fluid biomarkers for Alzheimer’s disease diagnosis: A Review.

2018

https://www.clinicalkey.com/#!/content/playContent/1-s2.0-S1552526018301626?returnurl=https:%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS1552526018301626%3Fshowall%3Dtrue&referrer=https:%2F%2Fwww.ncbi.nlm.nih.gov%2Fpubmed%2F%3Fterm%3DThe%2Bimpact%2Bof%2Bpreanalytical%2Bvariables%2Bon%2Bmeasuring%2Bcerebrospinal%2Bfluid%2Bbiomarkers%2Bfor%2BAlzheimer's%2Bdisease%2Bdiagnosis%253A%2BA%2Breview

Hansson O, Mikulskis A, Fagan AM, Teunissen C, Zetterberg H, Vanderstichele H, Molinuevo JL, Shaw LM, Vandijck M, Verbeek MM, Savage M, Mattsson N, Lewczuk P, Batrla R, Rutz S, Dean RA, Blennow K.

Alzheimers Dement. 2018-10-01, Volume 14, Issue 10, Pages 1313-133.